About
Products
Services
Applications
Knowledge
About
- About Svar
- Career
- Distributors
- Events
- Complement Excellence Award
- News
Products
- All Products
- Complement Assays
- Cell-Based Assays
- Gene Therapy Assays
- CCP Assays
Services
- CRO Services
- Diagnostic Services
- Custom Cell Development
- Cell Manufacturing
Applications
- Potency Testing
- Safety Assessment
- Biomarker Profiling
- Clinical Assessment
- Bioanalysis
- Regulatory Testing
- Complement System Evaluation
- Gene & Cell Therapy Evaluation
- Biosimilar & Biobetter Assessment
- Metabolic Therapeutics Evaluation
Knowledge
- Scientific Resources
- Product Documentation
About
Svar offers a unique combination of scientific expertise, high-quality assay products, strong services, and proprietary technology platforms that provide a flexible and seamless experience for different customer needs.
About Svar
Life science is always asking new questions. It's essential to the discovery process.
Career
We are always interested in finding new talented individuals to join our team, from new graduates to experienced professionals.
Distributors
We collaborate with our valued distributors to provide our technology to end customers worldwide, leveraging our distributors' local knowledge and expertise
Events
Join us at leading life science events worldwide. Explore our Event Calendar for a full-year view of major conferences and scientific gatherings.
Complement Excellence Award
The Svar Complement Excellence Award recognizes outstanding contributions to the complement field by scientists and physicians worldwide. Find out more about how to apply and previous winners.
News
Stay up to date with the latest developments, announcements, and expert perspectives.
Products
View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
All Products
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Complement Assays
Functional and biomarker assays for the exploration of every angle of the complement system
Cell-Based Assays
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
Gene Therapy Assays
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
CCP Assays
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Services
We offer high-quality flexible services in many areas within life science. Our CRO Services offer extensive bioanalytical, biomarker discovery, and QC testing services in a GMP setting.
In addition, we offer expert diagnostic services for autoimmune and neurological disorders, as well as cell and manufacturing services.
CRO Services
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
Diagnostic Services
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Custom Cell Development
Let us develop a custom iLite® cell line tailored to your needs.
Cell Manufacturing
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
Applications
Our solutions for drug development, diagnostics, and regulatory compliance – covering everything from therapeutic applications and biomarker testing to bioanalysis and quality assurance
Potency Testing
Explore how our expertise in potency testing, functional characterization, and immunogenicity assessment can support your drug development journey from discovery through regulatory submission
Safety Assessment
Ensure therapeutic safety with our immunogenicity assays, hemocompatibility panels, and complement pathway testing designed to meet global regulatory standards.
Biomarker Profiling
From multiplex ELISA to custom biomarker assay development, we help you generate actionable insights for precision medicine.
Clinical Assessment
Our CE-marked diagnostic kits and specialized services enable accurate disease detection and patient stratification for personalized treatment strategies.
Bioanalysis
Our GLP-compliant bioanalytical services provide accurate PK, TK, and PD data through optimized workflows and sensitive biomarker assays for regulatory success.
Regulatory Testing
Achieve full regulatory compliance with our GMP-qualified QC testing for biologics and biosimilars, ISO 15189-accredited diagnostic services, and customized cell-based solutions.
Complement System Evaluation
Access a complete portfolio of complement ELISAs, biomarker panels, and functional assays to evaluate complement pathways and support safety and efficacy studies.
Gene & Cell Therapy Evaluation
Accelerate advanced therapy development with our custom potency assays, AAV-specific safety platforms, and mechanism-of-action reflective cell-based solutions backed by GMP expertise.
Biosimilar & Biobetter Assessment
Demonstrate comparability and functional performance with our side-by-side assay panels, Fc-effector function testing, and iLite® bioassays tailored for biosimilars and biobetters.
Metabolic Therapeutics Evaluation
Our Metabolic Panel provides a set of reporter assays designed for the development of next-generation therapeutics for metabolic diseases.
Knowledge
Valuable resources, webinars, downloads, and more. Get the latest white papers, safety data sheets, and instruction manuals
Scientific Resources
Explore our collection of white papers, technical notes, posters, webinars, and our list of peer-reviewed publications highlighting how our technologies are used across diverse applications.
Product Documentation
Instruction manuals, safety data sheets, certificates, and more for Svar's products.
- BM5028 iLite® CD20 (+) Svar Luc Assay Ready Cells
- BM5001 iLite® ADCC Effector FcγRIIIa (V)
- BM5004 iLite® ADCP Effector FcγRIIa
- BM4110 iLite® GIP Assay Ready Cells
- BM4100 iLite® GLP-1 Assay Ready Cells
- BM4073 iLite® C3a Assay Ready Cells
- BM4075 iLite® C5a Assay Ready Cells
- BM4052 iLite® RANKL Assay Ready Cells
- BM4044 iLite® TNF-alpha Xcel Assay Ready Cells
- BM4049 iLite® Type I IFN FAST Assay Ready Cells
- BM3071 iLite® FGF-21 Assay Ready Cells
- BM4055 iLite® G-CSF Assay Ready Cells
- BM4050 iLite® GM-CSF Assay Ready Cells
- BM4021 iLite® VEGF Assay Ready Cells
- BM4080 iLite® hCG Assay Ready Cells
- BM3060 iLite® Insulin Assay Ready Cells
- BM4023 iLite® IL-23 Assay Ready Cells
- BM4012 iLite® IL-12 Assay Ready Cells
- BM4002 iLite® IL-2 Assay Ready Cells
- BM4061 iLite® IL-6 Assay Ready Cells
- BM4025 iLite® TLR4 Assay Ready Cells
- BM6069 iLite® TLR9 Assay Ready Cells
- BM6100 iLite® AAV Responsive Reporter Assay Ready Cells
- BM6002 iLite® AAV2 Packaging Assay Ready Cells
- BM6005 iLite® AAV5 Packaging Assay Ready Cells
- BM6006 iLite® AAV6 Packaging Assay Ready Cells
- BM6008 iLite® AAV8 Packaging Assay Ready Cells
- BM6009 iLite® AAV9 Packaging Assay Ready Cells
- BM5005 iLite® CD3 Effector
- BM5025 iLite® CD19 (+) Target
- BM5026 iLite® CD19 (-) Target
- BM5010 iLite® CD20 (+) Target
- BM5015 iLite® CD20 (-) Target
- BM5035 iLite® EGFR (+) Target
- BM5036 iLite® EGFR (-) Target
- BM5011 iLite® HER2 (+) Target
- BM5016 iLite® HER2 (-) Target
- BM5013 iLite® mTNF-alpha (+) Target
- BM5014 iLite® mTNF-alpha (-) Target
- BM5017 iLite® mVEGF (+) Target
- BM5018 iLite® mVEGF (-) Target
- AAV9COMPLRUO AAV9-induced Complement Activation ELISA
- COMPL FPQ RUO Complement Factor P Quantitative Assay
- COMPL TCC RUO Complement TCC
- COMPL C4d RUO Complement C4d
- COMPL FPF RUO Complement Factor P Functional Assay
- COMPLAP330 WIESLAB® Complement Alternative Pathway (IVD)
- COMPLAP330RUO WIESLAB® Complement Alternative Pathway (RUO)
- COMPLCP310 WIESLAB® Complement Classical Pathway (IVD)
- COMPLCP310RUO WIESLAB® Complement Classical Pathway (RUO)
- COMPLMP320 WIESLAB® Complement MBL Pathway (IVD)
- COMPLMP320RUO WIESLAB® Complement MBL Pathway (RUO)
- COMPL300 WIESLAB® Complement Screen (IVD)
- COMPL300RUO WIESLAB® Complement Screen (RUO)
- RA-96 PLUS IMMUNOSCAN CCPlus® (IVD)
- RA-96 PLUS RUO IMMUNOSCAN CCPlus® (RUO)
- 002 GBM-antikroppar (IgG)
- 008 C-/P-ANCA
- 011 PR3-ANCA (IgG)
- 015 MPO-ANCA (IgG)
- 017 Kardiolipin-antikroppar (IgA)
- 018 Autoimmun leversjukdom Screen
- 020 ANA (HEp-2)
- 023 dsDNA-antikroppar (IgG)
- 024 ANA-specificiteter
- 025 Sm-antikroppar
- 027 SSA/Ro60-antikroppar
- 028 SSB/La-antikroppar
- 031 Ribosomalt P-protein (Ribo-P)-antikroppar
- 032 SSA/Ro52 -antikroppar
- 047 FGFR3-antikroppar (IgG)
- 052 Dopamin-2 receptor-antikroppar (IgG)
- 071 Endomysium-antikroppar (IgA)
- 074 Transglutaminas-antikroppar (IgA)
- 079 Acetylkolinreceptor-antikroppar
- 080 Agrin-antikroppar
- 082 Glattmuskel-antikroppar (SMA)
- 084 Mitokondrie-antikroppar (AMA)
- 086 Binjurebark-antikroppar
- 087 Parietalcells-antikroppar
- 089 GAD-antikroppar
- 090 Ö-cells-antikroppar
- 093 MAG-antikroppar
- 095 HSP-70-antikroppar
- 098 Histon-antikroppar
- 100 GBM-antikroppar (IgG4)
- 105 Erytropoietin
- 110 Insulin-antikroppar
- 111 IA-2-antikroppar
- 113 ZnT8-antikroppar
- 117 mGlur1-antikroppar (IgG)
- 118 mGlur5-antikroppar (IgG)
- 119 Neurofilament heavy chain (pNfH)
- 124 Infliximab
- 126 Adalimumab
- 128 Etanercept
- 130 Golimumab
- 132 Certolizumab
- 136 Natalizumab
- 138 Vedolizumab
- 140 THSD7A-antikroppar (IgG)
- 141 cN-1A (Mup44)-antikroppar (IgG)
- 146 Beta-2-Glykoprotein 1-antikroppar (IgA)
- 195 Autoimmun encefalit
- 199 Paraneoplastiskt syndrom (IIF och immunoblot)
- 205 Envoplakin-antikroppar (IgG)
- 220 Hu (ANNA-1)-antikroppar (IgG)
- 240 Streptolysin O-antikroppar
- 245 PLA2R-antikroppar IIF (IgG)
- 247 PLA2R-antikroppar ELISA (IgG)
- 260, 282 Bullös Pemfigoid (BP180/BP230) - antikroppar (IgG)
- 280 Kollagen VII-antikroppar (IgG)
- 291 HLA-DQB1*06:02 (Narkolepsi)
- 294 ApoE4 Genotypning
- 355 Sulfatid-antikroppar (IgM)
- 403 Fosfatidylserin-antikroppar (IgGAM)
- 404 Fosfatidylserin-antikroppar (IgA)
- 405 Fosfatidylserin-antikroppar (IgG)
- 406 Fosfatidylserin-antikroppar (IgM)
- 450 RNA Polymeras-antikroppar
- 460, 470 Desmoglein 1 och 3-antikroppar (IgG)
- 485 HMGCR-antikroppar
- 500 Glomerulonefrit – utvidgad analys
- 501 ANCA vaskulit/anti-GBM sjukdom (Goodpastures syndrom)
- 510 Antifosfolipidsyndrom (APS)
- 511 Systemisk lupus erythematosus (SLE)/Sjögrens syndrom
- 515 Autoimmun leversjukdom
- 516 Kardiolipin-antikroppar (IgG, IgM)
- 517 Beta-2-Glykoprotein 1-antikroppar (IgG, IgM)
- 520 Inflammatorisk systemsjukdom
- 522 Systemisk skleros/Sklerodermi
- 527 Systemisk skleros/Sklerodermi – utvidgad analys
- 530 Plötslig hörselnedsättning
- 531 Diabetes mellitus typ 1
- 533 Autoimmun nodopati/CIDP – utökad analys med reflex (IgG1-4)
- 534 Guillain-Barrés syndrom/AIDP
- 535 Fintrådsneuropati (SFN)
- 536 BPI-ANCA (IgG, IgA)
- 539 Fintrådsneuropati (SFN) – utökad analys
- 540 Autoimmun nodopati/CIDP – subclass screen (IgG1-4)
- 541 Läkemedelsinducerad lupus
- 543 Myastenia gravis
- 546 Gangliosider-antikroppar (IgG, IgM)
- 548 Myosit/Interstitiell lungsjukdom (ILD) Screen
- 549 Neuromyelitis optica spectrum disease (NMOSD) – skademarkörer
- 550 Blåsdermatos
- 555 Inflammatorisk myopati (Myosit)/Interstitiell lungsjukdom (ILD)
- 557 Alzheimers sjukdom biomarkörer – utökad analys
- 558 Narkolepsi
- 560 Autoimmun encefalit, Paraneoplastiskt syndrom och Cerebellär ataxi
- 561 Neuromyelitis optica spectrum disease (NMOSD)/MOGAD – Live CBA
- 562 Neuronala-antikroppar – utökad analys
- 563 Lambert Eatons myastena syndrom (LEMS)
- 565 Neuromyelitis optica spectrum disease (NMOSD)/MOGAD
- 566 CNS parenkymskademarkörer
- 567 Alzheimers sjukdom biomarkörer
- 568 Stiff person syndrom
- 569 Paraneoplastisk retinopati (MAR/CAR)
- 570 Komplementaktivering
- 571 Hereditärt angioödem (HAE)
- 572 Komplementfunktion/brist
- 573 Komplementfunktion
- 574 Ofelias syndrom (Paraneoplastisk cerebellär ataxi/Limbisk encefalit)
- 575 Autoimmun pankreatit typ 2 (AIP2)
- 579 Antifosfolipidsyndrom (APS) – utökad analys
- 580 Amyotrofisk lateral sclerosis (ALS) biomarkörer
- 581 Multipel skleros (MS)
- 584 Primär membranös nefropati (PMN)
- 585 Autoimmun epilepsi
- 586 Autoimmun epilepsi – utökad analys
- 587 Pediatrisk autoimmun encefalit
- 588 Pediatrisk autoimmun encefalit – utökad analys
- 600 Fibrillarin-antikroppar
- 603 Rituximab
- 605 Ustekinumab
- 607 Tocilizumab
- 613 Eculizumab
- 615 Abatacept
- 620 Autoimmun nodopati/CIDP – screen IgG
- 710 PM/Scl (100kD)-antikroppar
- 720 Th/To-antikroppar
- 730 Amfifysin-antikroppar (IgG)
- 736 Recoverin-antikroppar (IgG)
- 737 SOX1-antikroppar (IgG)
- 740 Yo (PCA-1)-antikroppar (IgG)
- 742 Zic4-antikroppar (IgG)
- 750 Ri (Nova 1/ ANNA-2)-antikroppar (IgG)
- 760 Tr-antikroppar (IgG)
- 761 PCA-2-antikroppar
- 772 AMPA receptor 1/2-antikroppar (IgG)
- 780 21-Hydroxylas-antikroppar
- 790 Ma (Ma-2/Ta)-antikroppar (IgG)
- 804 TS-HDS-antikroppar (IgM)
- 805 Plexin D1-antikroppar (IgG)
- 831 VGKC-antikroppar (IgG)
- 833 LGI-1-antikroppar (IgG)
- 835 CASPR2-antikroppar (IgG)
- 837 alfa-Enolase-antikroppar
- 838 Glycinreceptor-antikroppar (IgG)
- 839 Ryanodin receptor 1 (RyR1)-antikroppar
- 845 VGCC-antikroppar
- 850 Carbonic Anhydrase II-antikroppar
- 851 DPPX-antikroppar (IgG)
- 852 IgLON5-antikroppar (IgG)
- 854 CARP VIII-antikroppar (IgG)
- 855 HOMER3-antikroppar (IgG)
- 856 ITPR1-antikroppar (IgG)
- 859 Laktoferrin (DNA bundet)-antikroppar (IgG)
- 868 KCNA2-antikroppar (IgG)
- 870 CV2/CRMP-5-antikroppar (IgG)
- 871 Neurochondrin-antikroppar (IgG)
- 872 Neurexin-3 alpha-antikroppar (IgG)
- 874 ANNA-3-antikroppar
- 875 NMDA receptor-antikroppar (IgG)
- 876 GABA A receptor-antikroppar (IgG)
- 877 GABA B receptor-antikroppar (IgG)
- 878 Sez6L2-antikroppar (IgG)
- 880 Aquaporin 4 (AQP4) -antikroppar (IgG)
- 883 Aquaporin 4 (AQP4)-antikroppar (IgG) – Live CBA
- 884 MOG-antikroppar (IgG)
- 885 MOG-antikroppar (IgG) – Live CBA
- 890 C1q-antikroppar
- 900 C3
- 910 C4
- 920 C1q
- 925 C1-INH nivå
- 926 C1-INH funktion
- 930 C3d
- 931 Properdin
- 957 KLHL11-antikroppar (IgG)
- 958 Lrp4-antikroppar
- 959 Ganglionära AChR-antikroppar
- 960 MuSK-antikroppar (IgG)
- 965 Titin-antikroppar (IgG)
- 970 Trib2-antikroppar
- 986 Neurogranin
- 987 pTau-181
- 988 CXCL13
- 989 Orexin (Hypokretin-1)
- 990 Tau
- 991 pTau
- 992 Beta-Amyloid 42
- 994 Neurofilament light (NfL)
- 996 GFAp-antikroppar (IgG)
- 997 Beta Amyloid kvot 42/40
- 985 Glial fibrillary acidic protein (GFAP)
- 200 Neuronal antikroppsscreen – Tissue based assay (TBA)
- 502 Autoantikroppar vid demensliknande tillstånd
- 506 Inflammatorisk neuropati screen – utökad analys
- iLite
- Complement
- Calpro
